Glucocorticosteroids for patients undergoing laparoscopic cholecystectomy

To determine the beneficial and harmful effects of glucocorticoids for reducing PONV or both in patients undergoing laparoscopic cholecystectomy relative to placebo or alternative antiemetic agents.

This is a protocol.

You may also be interested in:

Different methods of cystic duct occlusion in patients undergoing laparoscopic cholecystectomy
Intra-abdominal local anaesthetic administration in people undergoing laparoscopic cholecystectomy
Formal education of patients about to undergo laparoscopic cholecystectomy
Robot assistant versus human or another robot assistant in patients undergoing laparoscopic cholecystectomy
Intra-peritoneal saline instillation versus no instillation for laparoscopic cholecystectomy

Health topics:

Gastroenterology & hepatology > Gallbladder & bile duct disease > Gall stones: gallbladder

Published:

6 October 2010

Authors:

Malik AIrqam, Tou S, Ritchie JE, Hardman NL, Malakun R, Cleary SL, Malik NU, Aggarwal SS, Erskine SE, Nelson RL

Primary Review Group:

Hepato-Biliary Group

See the full Review on

the Cochrane Library

►

Print
PDF
Citation
Malik AIrqam, Tou S, Ritchie JE, Hardman NL, Malakun R, Cleary SL, Malik NU, Aggarwal SS, Erskine SE, Nelson RL. Glucocorticosteroids for patients undergoing laparoscopic cholecystectomy. Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No.: CD008733. DOI: 10.1002/14651858.CD008733

Don't show again

You can help make health evidence easier to understand! No experience or expertise needed, just 30 minutes to volunteer for a study where you will read 2 summaries and answer questions. If interested, click here to provide your email for more information - it will not be used for anything else.